László, Zsófia I. http://orcid.org/0000-0001-5317-1207
Lele, Zsolt http://orcid.org/0000-0003-2672-144X
Zöldi, Miklós
Miczán, Vivien http://orcid.org/0000-0003-0457-4899
Mógor, Fruzsina
Simon, Gabriel M.
Mackie, Ken http://orcid.org/0000-0001-8501-6199
Kacskovics, Imre http://orcid.org/0000-0002-0402-3862
Cravatt, Benjamin F. http://orcid.org/0000-0001-5330-3492
Katona, István http://orcid.org/0000-0003-2808-3330
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (DA021696, DA011322, DA037660)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 28 November 2019
Accepted: 3 August 2020
First Online: 31 August 2020
Competing interests
: I. Kacskovics is a scientific co-founder of ImmunoGenes Ltd., a company specialized in the generation of FcRn transgenic animals for the production of polyclonal and monoclonal antibodies. All the other authors declare no competing interests.